The Middle East & Africa parenteral nutrition market size is expected to reach USD 346.0 million by 2030, registering a CAGR of 4.4%. The MEA parenteral nutrition market is expected to witness lucrative growth over the forecast period owing to various parameters such as presence of large pool of malnourished children, rising premature births, increasing adoption by healthcare settings for nutrient administration in chronically ill geriatric patients, and rising prevalence rate of cancer within the region.
Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.
Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.
This product will be delivered within 1-3 business days.
Increasing prevalence of chronic conditions such as cancer unswervingly influences the use of parenteral nutrition across the globe. Parenteral nutrition helps in the administration of key vital nutrients that are useful in maintaining strength, energy, and hydration level in cancer patients, thus, acting a vital impact rendering driver expected to surge market growth over the forecast period.
Similarly, predominant existence of malnourished children and premature neonates that require these nutrients, is expected to further propel the growth. According to statistics published by the Knoema, a public data platform, the prevalence of the malnutrition in Middle East and North Africa in 2013 was around 6.04%, however, it has witnessed a decline over the period of time.
Middle East & Africa Parenteral Nutrition Market Report Highlights
- Single dose amino acid solutions held a dominant share in 2023. This dominance is governed by the influx of innovative products. In addition, these innovative formulations are more efficient and cause lesser adverse effects.
- Intravenous lipid emulsions are anticipated to witness lucrative growth over the forecast period. Drug delivery through lipid emulsion is expected to showcase promising results as it results in minimal adverse effects such as irritation, pain, and thrombophlebitis.
- Adults dominated the market and accounted for 85.9% in 2023. The compromised gastrointestinal function, prolonged malnutrition, and increased malnutrition in adults drive the segmental growth.
- Cancer care dominated the market and accounted for a market share of 16.9% in 2023. It can be attributed to the rising cancer cases in the Middle East and African region.
- Institutional sales channels dominated the market and accounted for a market share of 49.2% in 2023. The large share of the segment can be attributed to the increasing allowance for the adoption of technologically advanced medical devices and parenteral nutrition solutions in settings such as hospitals and clinics.
The leading players in the Middle East & Africa Parenteral Nutrition market include:
- B. Braun Melsungen SE
- Baxter
- Fresenius Kabi AG
- Qatar Pharma Factory
- Hospira (now part of Pfizer Inc.)
- Evonik
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. MEA Parenteral Nutrition Market Variables, Trends, & Scope
Chapter 4. MEA Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
Chapter 5. MEA Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis
Chapter 6. MEA Parenteral Nutrition Market: Indication Estimates & Trend Analysis
Chapter 7. MEA Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis
Chapter 8. MEA Parenteral Nutrition Market: Regional Estimates & Trend Analysis
Chapter 9. Competitive Landscape
Companies Mentioned
The leading players in the Middle East & Africa Parenteral Nutrition market include:- B. Braun Melsungen SE
- Baxter
- Fresenius Kabi AG
- Qatar Pharma Factory
- Hospira (now part of Pfizer Inc.)
- Evonik
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 80 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 256.5 Million |
| Forecasted Market Value ( USD | $ 346 Million |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Africa, Middle East |
| No. of Companies Mentioned | 7 |
